eMDI Connected Metered-Dose Inhaler

H&T Presspart has developed the first market-ready, fully embedded and connected metered-dose inhaler (eMDITM). By tracking and recording data on the use of medications, and sharing it with patients and physicians via a mobile or web app, the eMDI enables pharmaceutical manufacturers to bring the best possible care to those with asthma and COPD. The eMDITM improves patients' adherence to medication doses, encourages self-care, and helps health professionals maintain real-time monitoring. The device can integrate with a mobile health app that can track both controller and rescue medications. It then transfers the data wirelessly to a smart phone app, or can even send information directly into a patient's medical records.